Wird geladen...
Next-generation personalized drug discovery: the tripeptide GHK hits center stage in chronic obstructive pulmonary disease
Chronic lung diseases (CLDs), including chronic obstructive pulmonary disease (COPD), are the second leading cause of death worldwide. The first report of database-driven drug discovery in carefully phenotyped COPD specimens has now been published in Genome Medicine, combining gene expression data i...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2012
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3580440/ https://ncbi.nlm.nih.gov/pubmed/22999295 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/gm371 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|